CryptoSafe Raises $20M in Updated Funding; Valued at $95M
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Nextech Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
A regularly updated list of mergers and acquisitions in the European tech sector
OrbiMed-incubated Theseus unveils $100M to beat cancer drug resistance OrbiMed-incubated Theseus unveils $100M to beat cancer drug resistance Incubated by OribMed and led by Ariad Pharmaceuticals veterans, Theseus Pharmaceuticals unveiled $100 million in Series B financing to develop the next generation of tyrosine kinase inhibitors, a type of cancer drug. The company expects to enter the clinic by the end of 2021. Shares0 One of the challenges of treating cancer is the ability of cancer cells to mutate, which leads to resistance to currently available therapies. Theseus Pharmaceuticals h...